Advanced in Peripheral T-Cell Lymphoma

Matthew P. Greenwood

MBBS, DM, St Vincent's Hospital Sydney, 
Sydney, NSW, AU 
Advanced in Peripheral T-Cell Lymphoma
MBBS, DM, St Vincent's Hospital Sydney, 
Sydney, NSW, AU 
OverviewLocationsClinical Research

Overview

Matthew Greenwood practices in Sydney, Australia. Mr. Greenwood is rated as an Advanced expert by MediFind in the treatment of Peripheral T-Cell Lymphoma. His top areas of expertise are Peripheral T-Cell Lymphoma, Bronchiolitis Obliterans, Mouth Ulcers, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

His clinical research consists of co-authoring 73 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Peripheral T-Cell Lymphoma.

Gender
Male

Locations

MBBS, DM, St Vincent's Hospital Sydney, Sydney, NSW, Australia
Other Locations
St Leonards, NSW 2064, Australia
Richmond, VIC, Australia
Camperdown, NSW, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2025
Intervention Type: Drug
Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone
Study Phase: Phase 3

73 Total Publications

Reply to: Reproducibility of Clinically Meaningful Change in Physical Capacity Tested by Online 6-Minute Walk Test.
Reply to: Reproducibility of Clinically Meaningful Change in Physical Capacity Tested by Online 6-Minute Walk Test.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Greenwood's expertise for a condition
ConditionClose
      View All 27 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile